I'm linking this page to help raise awareness of a funding campaign by the National Cyclocross team in Ireland to help develop opportunities for riders, Helen.
The Irish Cyclocross Development fund exists to raise capital and funding to provide support and resources for cyclocross riders in Ireland, both North and South.
The ICD fund has been established by Irish cyclocross fans and riders to raise much needed funds for overseas events including the 2019 World Championships in Denmark. Funding will go towards travel and race expenses for races outside Ireland and provide young racers with experiences to broaden their development.
The Cycling Development Fund exists to raise capital and funding, providing support and resources for growing the base of cyclocross – particularly the development of the junior and youth fields.
To launch the fund, we have a fantastic prize draw with some great cyclocross related prizes, including signed skin suits, official race kits and much more.
Prizes will be added to the draw as the days and weeks progress. Prizes include:
Jeremy Powers signed Rapha skin suit
Helen Wyman signed Race Jersey
Helen Wyman signed race numbers
Katie Compton signed USA Champions skin suit
Katie Compton World Cup signed race numbers
Katie Compton Signed Race cards
Belgium National Champion Bioracer Skin Suit
Belgium National Team ‘Telenet Fidea’ World Championship Bioracer Skinsuit
Belgium National Team World Championship Bioracer Skinsuit
UCI World Cup Cyclocross Leaders Santini Skinsuit
Tickets for the draw are priced at £5 each or purchase 3 tickets for £10.
100% of funds received from ticket sales goes to the fund. Click on the donate button below.
Prizes will be drawn on Saturday 23rd December 2018.
PARTNERS & CORPORATE CONTRIBUTORS
Existing partners benefit from brand exposure, social media recognition, website links and promotion along with rider recognition.
If you would like to contribute prizes to the prize draw or require additional information, then please contact us at email@example.com
ALL CONTACT FOR THIS PAGE IS FROM MARCUS CROMIE AND KEVIN DEVLIN